The Efficacy of Combined Therapy of Regorafenib with Detoxicating and Stasis Softening Chinese Herbal Spleen Tonics in Mid-/Late-Stage Hepatocellular Carcinoma

<div>Immunohistochemistry staining (a), western blot (b) and mRNA quantification (c) of tumors obtained from xenograft mice model treated with regorafenib, DSS-splenic tonics, Regorafenib + DSS-splenic tonics and control.</div>

Contrast Media & Molecular Imaging

fig3

Figure 3

Figure 3: The Efficacy of Combined Therapy of Regorafenib with Detoxicating and Stasis Softening Chinese Herbal Spleen Tonics in Mid-/Late-Stage Hepatocellular Carcinoma 

Figure 3 | The Efficacy of Combined Therapy of Regorafenib with Detoxicating and Stasis Softening Chinese Herbal Spleen Tonics in Mid-/Late-Stage Hepatocellular Carcinoma 